KEYNOTE145
Phase 1/2 Completed
161 enrolled 29 charts
SANGUINE
Recruiting
3,000 enrolled
MargheRITA
Phase NA Completed
124 enrolled
Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies
Phase 1 Completed
106 enrolled
MK-3475-013
Phase 1 Completed
197 enrolled 52 charts
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Phase 2 Completed
19 enrolled 22 charts
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
Phase 2 Completed
12 enrolled 5 charts
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Phase 2 Completed
12 enrolled 10 charts
TXA127-PBSC
Phase 2 Terminated
75 enrolled
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
RENAL
Phase 1 Completed
31 enrolled 30 charts
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Phase 2 Completed
33 enrolled 22 charts
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
Phase 1 Completed
48 enrolled 26 charts
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies
Phase 1/2 Completed
38 enrolled
Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
Phase 1 Terminated
2 enrolled
EAP
No longer available
PREDICT
Phase 3 Completed
118 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
Phase 2 Completed
5 enrolled
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Phase 2 Terminated
1 enrolled
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Phase 1 Completed
56 enrolled
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Phase 1 Completed
7 enrolled
Repeat Dose Safety Study for Compound to Treat Hematologic Cancer
Phase 1/2 Completed
73 enrolled
Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
Phase 1 Withdrawn
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
Phase 1 Completed
36 enrolled
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Phase 1 Completed
72 enrolled